Stock DVAX DYNAVAX TECHNOLOGIES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Dynavax Technologies Corporation

Equities

DVAX

US2681582019

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
11.39 USD +2.52% Intraday chart for Dynavax Technologies Corporation +3.26% -18.53%
May. 14 Dynavax Technologies Notified by US FDA That Application for Four-Dose Course of Hepatitis B Vaccine Lacks Sufficient Data MT
May. 14 Dynavax Application for Hepatitis B Treatment Ruled Insufficient by FDA DJ

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. DVAX Stock
  4. Revisions Dynavax Technologies Corporation
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW